Cleaning Validation Summit 2024 - uventia

Cleaning Validation Summit 2024

Cleaning Validation Summit
Event Details

CONFERENCE OVERVIEW

Drug products and active pharmaceutical ingredients (APIs) may be contaminated by other drug products or APIs, raw materials, intermediates, cleaning aids, microorganisms, particles and other materials. Contamination causes costly raw materials to be scrapped, triggers regulatory actions and, most importantly, endangers the safety of patients.

In order to avoid contamination of the product, robust cleaning procedures must be performed. Our online meeting facilitates peers’ reflection and discussion on approaches to establishing and revising CV programs to meet regulatory requirements, verifying CV protocols and preventing ineffective or incorrect approaches to cleaning validation programs, risk based cleaning validation, selecting the right equipment/cleaning procedure combinations, testing for API residues and calculating residue limits, considerations on combining cleaning and sanitization, finding and developing practical analytical methods and sampling procedures.

Be a part of our webinar sessions to build practical and compliant cleaning validation program and ensure that the quality of your next product is not affected by contamination.

WE WILL BE FOCUSING ON

  • QRM in Cleaning Validation
  • Cleaning Validation in shared facilities
  • Product bracketing and equipment grouping during Cleaning Validation
  • CIP Cleaning process optimization and sustainability
  • Maintaining the Cleaning Validation program
  • Regulatory and GMP aspects for Cleaning Validation
  • Developing suitable analytical methods
  • Sampling methods and sampling recoveries
  • Establishing acceptance limits
  • Selection of Cleaning agents
  • Visual inspection for Cleaning Validation
  • Microbiological aspects of Cleaning Validation

WHO IS IT FOR?

CxO, VP, Directors, Heads, Managers of

  • Cleaning Validation/ Containment
  • Bioprocessing/ Bioproduction
  • Aseptic Processing/ Sterility Assurance
  • Manufacturing Science & Technology/ Good Manufacturing Practice (GMP)
  • Cleaning Products/ Detergents
  • Risk Management/ Quality Assurance/ Quality Control
  • Analytical Development/ Analytical Methods
  • Regulatory Affairs/ CMC
Agenda-CV

[Agenda] Cleaning Validation Summit 2024

Download the full summit program to find speaker biographies, case studies, key takeaways, the day's schedule, and details of each session.

Speaking Companies

Media Partners

● Agilent ● Almac Group ● Amgen ● ANTIBIOTICE S.A. ● Avara ● B.Braun Surgical ● BD ● Biosynth B.V. ● Biotechnology & Pharma Consulting GmbH ● Blue Pearl Medical ● Bristol Myers Squibb ● Cerbios-Pharma SA ● ConvaTec ● Delpharm Montréal Inc. ● Dottikon Exclusive Synthesis AG ● Esteve Quimica ● Genera d.d. ● Innovative pharma lab ● Janssen Cilag AG ● Johnson & Johnson ● Kyowa Kirin Co., Ltd. ● Lavipharm S.A ● LEO Pharma ● Lonza ● Merck Life Science KGaA ● Mérieux NutriSciences ● Microsin SRL ● Mindful Quality ● Moebius Medical LTD ● Octapharma Biopharmaceuticals GmbH ● Orion Corporation ● Pfizer ● Pfizer (Retired) ● Praxis Packaging Solutions ● SafeBridge Consultants ● SafeBridge Europe, Ltd. ● Saneca Pharmaceuticals ● Sanofi ● Servier Ireland Industries Ltd ● STERIS Corporation ● Takeda ● Terumo Aortic ● UCB Farchim ● ValGenesis ● Validation Resolution ● Zoetis

Speaker Board
Ram Kouda
Scientific Associate Director
Amgen
Rui Almeida
Director Consultancy Services
ValGenesis
Ute Reichert
CEO
Biotechnology & Pharma Consulting GmbH
Witold Woroniecki
Senior Managing Consultant, Analytical Services
SafeBridge Consultants
Liz Dallison
Principal Scientist Cleaning Validation lead
Pfizer
Jenna Carlson
President & Quality Consultant
Mindful Quality
Brian Bosso
Technical Service Manager
STERIS Corporation
Brook Meadows
Senior Technical Service Associate
STERIS Corporation
William A. Hawkins
Managing Toxicologist
SafeBridge, Europe
Mariann Neverovitch
Sr. Manager Logistics Operations
Bristol-Myers Squibb
Fred Ohsiek
Principal Cleaning Process Consultant
Validation Resolution

Summit Agenda

◆  Apply a lifecycle approach to cleaning validation, from process design (Phase I) to process qualification (Phase II) and continued process verification – CPV (Phase III).

◆  A methodology applied for each phase is presented with examples of what elements should be considered when building a CV strategy.

◆  Present a workflow for the creation of a risk-based cleaning CPV plan with key performance metrics to ensure process consistency and where process insights are used for continuous improvement throughout process life cycle.

◆  Benefits of going digital in end-to-end cleaning validation life-cycle management.

◆  What is a Permitted Daily Exposure (PDE).

◆  Calculation and Implementation.

◆  Regulatory Implications.

◆  Bracketing and grouping regulatory expectations.

◆  Common mistakes and misconceptions when bracketing and grouping.

◆  Science and risk-based approaches when grouping.

◆  Equipment grouping case study.

◆  CIP cleaning recipe.

◆  Elements of an optimized cleaning process.

◆  How to efficiently optimize a CIP cleaning process.

◆  Hidden benefits of optimizing legacy cleaning process.

◆  Explore cleaning development sampling strategy.

◆  Efficient restart after a shut-down and cleaning after maintenance.

◆  When re-validation makes sense.

◆  Explore process for creating an efficient and robust science risk-based CPV program.

◆  Routine monitoring case study.

◆  Protocol reporting and validation compliance.

◆  Regulatory emerging trends for industry.

◆  EMA and FDA guidelines.

◆  PIC/S, ICH guidelines.

◆  Current Health Agency observations & warning letters related to cleaning.

◆  Bench Scale studies to demonstrate the Biological protein degradation during the cleaning process.

◆  Application of cleaning induced fragments in MAC(maximum allowable carryover) and acceptance limit calculation.

◆  Application of sensitive Analytical method to demonstrate greater than 99% degradation during cleaning process.

Amgen, USA

◆  Product Contact vs non product contact surfaces.

◆ Selection of sampling points.

◆ Swabs VS rinse.

◆ Translating MACO to sample limits.

◆ Recovery studies.

◆  Acceptance criteria based on toxicity data (NOAEL, ADE/PDE, TTC).

◆  MACO levels for worst-case product.

◆  Challenges of establishing residual limits.

◆  Identifying the hazards with contamination data.

◆  Cleaning agents based on cleanability studies, cleaning method, supplier qualification.

◆  Rinsability of cleaning agents.

◆  The safety of cleaning agent.

◆  Limit calculations for cleaning agent residues.

◆  Benefits and limitations of visual inspection (VI).

◆  Establishing visual residue limits (VRL).

◆  Qualification of personnel and visual inspection training.

◆  Visual inspection, surface sampling and rinse sampling.

◆  Risk assessment and management as justification of VI.

◆  Equipment Cleaning is a critical GMP element of the Manufacturing Process. It ensures quality and safety of future batch. Cleaning Validation/verification is a measurement of the effectiveness of the cleaning process.

◆  In this presentation we will go over advantages and challenges of specific and non-specific analytical methods based on risk assessment of the residual product.

◆ Case studies, training and qualification programs will also be discussed.

◆  Cleaning, disinfection, sterility.

◆  Risk management.

◆ Microbiological testing and acceptance criteria.

◆ Microbiology flora.

◆ Microbial Aspects on cleaning Validation and CCS.

Event Details